Last updated 25 August 2026 · Originally published 16 January 2023
CBD patches stick to your skin and promise to release CBD into your bloodstream slowly over hours or days. The idea is pharmacologically plausible, and one commercially available patch has now been tested in people. What remains unproved is whether the patches on sale reliably deliver a meaningful dose, or provide any benefit once they do.
Patch is not the same as cream
Creams and balms are generally intended to work where you apply them, with most of the CBD remaining in or near the skin. A transdermal patch is meant to do something different: push CBD through the skin and into the blood, so it reaches the whole body without passing through the gut and liver first. That could sidestep the main reason so little swallowed CBD gets absorbed, and could produce a steadier level rather than a spike. Nicotine and some pain medicines are delivered this way, and it works well for them.
The catch is that skin is designed to keep things out. CBD dissolves in fat and barely at all in water, and how readily it crosses intact skin depends heavily on the formulation. Getting it through in useful amounts takes chemistry: penetration enhancers, the right base, the right dose.
It can be done — a drug company has shown it
The strongest pharmaceutical evidence that CBD can cross skin comes from a pharmaceutical gel called ZYN002, developed by Zynerba and now owned by Harmony Biosciences. It is synthetic CBD in a gel with a permeation enhancer, applied to the shoulders and arms at 250 to 500 mg a day. In its trials, CBD from the gel showed up in the blood, so the route works.
Whether it helped is a different question, and the results have been consistently disappointing. In a phase 3 trial of 212 children with Fragile X syndrome it did not beat placebo on its main measure across the whole group, although a later analysis suggested benefit in participants with at least 90% methylation of the FMR1 gene, the group in whom the gene is most fully switched off. A second phase 3 trial was designed around that subgroup, and in September 2025 it failed too, with the company blaming a large placebo response. Earlier trials in focal epilepsy and knee osteoarthritis had also missed their targets. The gel was generally well tolerated, with discomfort where it was applied the main treatment-related problem.
So a well-made transdermal CBD product can deliver CBD to the blood, but even at several hundred milligrams a day, that has not yet translated into a proven benefit.
What has been tested in shops
Consumer CBD patches commonly contain tens of milligrams of CBD and promise delivery lasting from several hours to several days. The amount printed on the package, though, is not the amount proven to enter the bloodstream, and package milligrams do not tell you how much crosses the skin.
A 2024 study at Johns Hopkins tested five commercially available CBD skin products — a cream, a lotion, a patch, a balm and a gel — in 46 healthy adults, used repeatedly over ten days. Seven people used the patch. CBD reached the bloodstream with three of the five products, but the amounts varied a great deal and were highest with a lotion that had both the largest CBD dose and a permeation enhancer. None of the products produced any effect the researchers could detect: not on mood, thinking, coordination or vital signs.
So retail products have been examined in people, and some do get CBD into the blood. What the study does not show is that CBD patches as a category deliver a reliable dose. Only one patch was tested, in seven people, and what one formulation does cannot be assumed of another.
What that means if you want to try one
Do not take “transdermal” on a package as proof of delivery into the blood. Some skin products can put measurable CBD there, but it is product-specific, and measurable is not the same as meaningful. Even the pharmaceutical gel, at several hundred milligrams a day, has not turned measurable into a proven benefit. Unless a company has tested its finished patch in people, its delivery rate is a marketing claim.
If you buy one anyway, the usual rules apply. Check the certificate of analysis so you know the CBD is there. Apply it to clean, dry, intact skin as directed, and stop using it if substantial irritation develops. And if the product quotes a delivery rate or a bioavailability figure, ask which human study it came from.
Nothing in this article is medical advice. If you take prescription medication, speak to a doctor or pharmacist before using CBD, as it can interact with a range of common drugs.
